We conclude that IKKα-dependent noncanonical NFκB pathway activation has the potential to drive the resolution of inflammation as well as subsequent TEC repair during the recovery phase of AKI through secretion of IL10 from Treg cells. The gene discussed is NFKB1; the disease is acute kidney injury.